Dong‐Ryeol Ryu

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Changes in Causative Organisms and Their Antimicrobial Susceptibilities in Capd Peritonitis: A Single Center's Experience over one Decade

Dong Ki Kim, Tae‐Hyun Yoo, Dong‐Ryeol Ryu et al. · Peritoneal Dialysis International · 2004 · 158 citations

Sirt1–hypoxia‐inducible factor‐1α interaction is a key mediator of tubulointerstitial damage in the aged kidney

Dong‐Ryeol Ryu, Mi Ra Yu, Kyoung Hye Kong et al. · Aging Cell · 2019 · 126 citations · Full text

Activation of the renin–angiotensin system within podocytes in diabetes

Tae‐Hyun Yoo, J.-J. Li, Jae‐Jin Kim et al. · Kidney International · 2007 · 110 citations · Full text

Physiology, Diabetes, Diabetic Kidney Disease +4

Impact of chronic kidney disease on mortality: A nationwide cohort study

Kyeong Min Kim, Hyung Jung Oh, Hyung Yun Choi et al. · Kidney Research and Clinical Practice · 2019 · 101 citations · Full text